Work

M-DODII: Bayesian dose optimization design for randomized phase II study with multiple indications

Year: 2025

Type: article

Source: Journal of Biopharmaceutical Statistics

DOI: 10.1080/10543406.2025.2589731

Authors: Sasha Amdur Kravets, Ziji Yu, Rachael Liu, Jianchang Lin

Institutions: Eli Lilly (United States), University of Illinois Chicago, Takeda (Japan)

Language: English

Topic: Statistical Methods in Clinical Trials

Subfield: Statistics and Probability

Field: Mathematics

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4416775462

FWCI: 0.871

Cites: 23

Cited by: 1

Related to: